Log in to save to my catalogue

Cardiovascular disease in SARS‐CoV‐2 infection

Cardiovascular disease in SARS‐CoV‐2 infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08bcd3eee61a484fa0195992647f7507

Cardiovascular disease in SARS‐CoV‐2 infection

About this item

Full title

Cardiovascular disease in SARS‐CoV‐2 infection

Publisher

Australia: John Wiley & Sons, Inc

Journal title

Clinical & Translational Immunology, 2021, Vol.10 (9), p.e1343-n/a

Language

English

Formats

Publication information

Publisher

Australia: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease. Acute cardiac complications include arrhythmia, myocarditis and heart failure, which are significantly ass...

Alternative Titles

Full title

Cardiovascular disease in SARS‐CoV‐2 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_08bcd3eee61a484fa0195992647f7507

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08bcd3eee61a484fa0195992647f7507

Other Identifiers

ISSN

2050-0068

E-ISSN

2050-0068

DOI

10.1002/cti2.1343

How to access this item